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Aim To assess the prognostic role of admission C-reactive 
protein (CRP) in patients with acute aortic dissection (AAD).
Methods We searched Medline and Scopus for studies 
published before January 2019 that evaluated the prog-
nostic impact of CRP on all-cause mortality during short- 
and mid-term follow-up period in patients with AAD. Ad-
ditional studies were identified by manual search of the 
references from the original studies. Receiver-operating 
characteristic curves were used to determine the opti-
mal cut-off values of admission CRP for the prediction of 
mortality, and patients were categorized into two groups 
based on the CRP cut-off levels.
Results Medline, Scopus, and manual literature search 
yielded 138 citations. Based on the title and abstract analy-
sis and review of potentially relevant studies, five studies, 
involving 711 patients, were included in the final analysis. 
Multivariate statistical analysis was performed in all the 
studies. The median admission CRP value across the studies 
was 13 mg/L (range 4-21 mg/L). Two out of three studies 
that evaluated in-hospital outcome and all of the studies 
that evaluated medium-term outcome reported a signifi-
cant association between elevated CRP values and mortal-
ity. The studies that included treatment strategy (surgery 
vs conservative treatment) as a confounding variable con-
firmed a significant effect of elevated CRP values on both 
in-hospital and mid-term unfavorable outcomes.
Conclusion This systematic review demonstrated a clear as-
sociation between elevated admission serum CRP levels and 
increased in-hospital and mid-term mortality risk in AAD.
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Accumulated evidence has shown that inflammation plays 
an important role in the pathogenesis of acute aortic dis-
section (AAD) (1). The association between inflammation 
and AAD was demonstrated with both positron emission 
tomography techniques and immune pathological analysis 
of the dissected aortic wall (1-3). Aortic wall inflammation in 
AAD was associated with higher serum C-reactive protein 
(CRP) levels, higher mortality rates, and major adverse events 
during medium-term follow-up (2). CRP is a simple marker, 
widely available and routinely used in everyday clinical prac-
tice. It has proved to be a useful marker of unfavorable out-
comes after acute coronary syndromes, but its prognostic 
role in AAD has not been extensively studied (4,5). Therefore, 
we performed a comprehensive systematic review of previ-
ous studies to investigate the prognostic effect of admission 
CRP on short- and mid-term mortality in patients with AAD.
PATIENTS AND METHODS
Search strategy
This systematic review was performed in accordance with 
the Meta-Analysis of Observational Studies in Epidemiol-
ogy (MOOSE) guidelines (6). We systematically searched 
Medline and Scopus for all studies published before Janu-
ary 2019 without language restriction, using the following 
medical subject headings: “C-reactive protein,” “CRP,” “aortic 
dissection,” “acute aortic syndrome,” and “mortality.” Addi-
tional studies were identified by manual search of refer-
ences of original or review studies.
Study inclusion and outcomes
We included observational cohort studies that evaluat-
ed the prognostic impact of admission CRP on all-cause 
mortality during short-term (length of hospital stay) and/
or medium-term (at least 12 months) follow-up period in 
patients with AAD. The inclusion criterion was aortic dis-
section (classified according to Stanford classification) pre-
senting within 14 days of symptom onset and confirmed 
with computed tomography scanning, transesophageal 
echocardiography, or magnetic resonance angiography. 
Receiver operating characteristic (ROC) curves were used 
to determine the optimal cut-off values of admission CRP 
for prediction of mortality. The patients were categorized 
into two groups based on the CRP cut-off levels.
Data extraction and quality assessment
Study selection and data extraction were conducted inde-
pendently by two investigators. All disagreements or dif-
ferences in the data extraction between the two authors 
were harmonized by consensus after the source data had 
been rechecked. Study quality was assessed using the vali-
dated Newcastle-Ottawa Scale for assessment of non-ran-
domized and observational studies, and studies were eval-
uated based on subject selection, comparability of study 
groups, and outcome assessment (7). Completed database 
contained the following data: the name of the first author, 
year of publication, country of origin, total number of pa-
tients in each study, study design, proportion of patients 
with hypertension, diabetes mellitus, and coronary artery 
disease, admission CRP, CRP cut-off values, in-hospital and 
mid-term mortality, follow-up period, adjusted effect esti-
mate, and confounding factors.
RESULTS
Selected studies and baseline characteristics
Medline and Scopus search yielded 138 citations, while 
manual literature search yielded one citation (8). Based 
on the title and abstract analysis and review of potentially 
relevant studies, six studies (9-14) were excluded and five 
studies were included in the final analysis (8,15-18) (Figure 
FIgURE 1. Study flow diagram for systematic review of C-reactive protein 
(CRP) and acute aortic dissection outcomes.
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1). The included studies involved 711 patients. Three stud-
ies were retrospective (15,17,18) and two were prospective 
(8,16). One study assessed in-hospital and medium-term 
mortality (15), two assessed only early mortality (16,17), and 
two assessed mid-term mortality (follow-up range 19-36 
months) (8,18). All the studies performed multivariate sta-
tistical analysis. The study characteristics are listed in Table 
1. The median age of the population was 69 years (range 49 
to 72 years), 63% (range 54% to 84%) were men, 81% (range 
46% to 93%) had hypertension, and 10% (range 8% to 28%) 
had diabetes. Median Newcastle-Ottawa score for included 
studies was 8 (range 7 to 9) (Table 2).
Qualitative data synthesis of included studies
CRP was measured on admission in four studies (8,16-18) 
and within 24 hours of admission in one study (15). It was 
determined by two types of highly sensitive assays: immu-
noturbidimetric assay in three studies (8,17,18) and immu-
nonephelometric assay in two studies (15,16). The medi-
an admission CRP value across the studies was 13 mg/L 
(range 4-21 mg/L). ROC curves were used to determine the 
optimal CRP cut-off values for the prediction of mortality in 
four studies (14-17) (median CRP 13.60 mg/L, range 9.80-
20.00 mg/L), and median CRP value (13 mg/L) was used as 
a cut-off in one study (Table 1) (8).
Four out of five studies comprised patients with both as-
cending and descending aortic dissections (8,15,16,18). Due 
to the relatively small number of patients in each study, and 
consequently small number of events, original studies were 
not powered to explore subgroups (ie, type A and type B 
AAD). Nevertheless, multivariate statistical analysis was per-
formed in all the studies, and treatment strategy and/or type 
of AAD were included as confounding variables.
Two out of three studies that evaluated in-hospital out-
come (16,17) (Figure 2A) and all studies that evaluated 
medium-term outcome (8,15,18) (Figure 2B) reported a 
significant association between elevated CRP values and 
mortality.
Four studies included treatment strategy (surgery vs con-
servative treatment) as a confounding variable (8,16-18). 
These studies confirmed a significant effect of higher CRP 
values on both in-hospital and mid-term unfavorable out-
comes (Table 1, Figure 2).
Therefore, based on adjusted estimates from all the in-
cluded studies, higher CRP proved to be a poor prognos- TA
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tic factor in AAD (Figure 2). However, each of the included 
studies used different cut-offs to classify participants as 
having higher and lower CRP values (Table 1). Because of 
this fact and the relatively small number of primary stud-
ies, a pooled unified estimate of the strength of association 
between CRP and short-term or medium-term mortality 
could not be performed. Of note, different CRP cut-offs 
obtained in the studies in this systematic review are bio-
logically plausible and can be partly explained by different 
population characteristics (ie, ethnicity) (Table 1).
Excluded studies
Two studies that originally investigated the prognostic role 
of high-sensitivity cardiac troponin T and plasma pentrax-
in-3 levels for hospital mortality in patients with type A 
AAD, also included the admission CRP values as a continu-
ous variable in the multivariate analysis (9,10). Both stud-
ies showed that, after multivariable adjustment, admission 
CRP was independently associated with in-hospital mor-
tality in patients with AAD (odds ratio [OR] 1.05; 95% confi-
dence intervals [CI] 1.01-1.09 and OR 1.67; 95% CI 1.24-2.63, 
respectively). So, CRP investigated either as a binary or con-
tinuous variable clearly showed an independent prognos-
tic value for hospital outcome in AAD.
In addition to admission CRP values, peak CRP and its pat-
tern during hospital stay was also investigated. Sakakura et 
al showed that peak CRP (19.50 vs 6.40 mg/dL) was an in-
dependent predictor for adverse long-term events (median 
follow-up 50 months) in type B AAD (hazard ratio [HR] 6.02, 
95% CI 2.44-14.87) (11). Similarly, in patients with aortic intra-
mural hematoma, a sustained elevation of CRP level (≥7.20 
mg/dL) at 2 weeks was an independent predictor of adverse 
aorta related events (HR 3.16, 95% CI 1.74-5.73) (12). In accor-
dance with the previous study, Makita et al (13) showed that 
re-elevation or retarded recovery of CRP in patients with 
AAD or intramural hematoma corresponded with intramu-
ral events. Correspondingly, Okina et al (14) demonstrated 
that distinct CRP pattern (prolonged CRP elevation and/or 
re-elevation) during hospital stay provided information on 
cardiovascular events (recurrent dissection and false-lumen 
enlargement) in patients with AAD. However, from the clini-
cal point of view repeated CRP measurements are impracti-
cal, since they are time-consuming and costly.
DISCUSSION
Our systematic review showed that elevated admission 
CRP levels indicated increased in-hospital and medium-
term mortality in AAD.
TAbLE 2. Newcastle-Ottawa Scale for studies included in the systematic review
Author, year (reference) Subject selection Comparability of study groups Assessment of outcome Total
Schillinger, 2002 (8) 4 2 3 9
AlMahameed, 2010 (15) 3 2 3 8
Wen, 2013 (16) 3 2 3 8
Vrsalovic, 2015 (17) 3 2 3 8
Mori, 2016 (18) 3 2 2 7
FIgURE 2. Forest plot showing the prognostic impact of C-reactive protein on (A) short-term mortality and (B) medium-term mortal-
ity in patients with acute aortic dissection (adjusted effect estimates are presented).
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Circulating biomarkers are attractive tools in diagnostic 
decision-making and risk stratification in acute aortic syn-
dromes. For instance, plasma D-dimer below the threshold 
level (ie, <500 ng/mL) is a useful screening tool to rule out 
AAD, but with a limited prognostic value (19-21). On the 
contrary, recently published studies showed that elevated 
cardiac troponin at the time of admission for aortic dissec-
tion was associated with an increased risk of short-term 
mortality (22,23).
CRP is a simple marker, widely commercially available, rel-
atively inexpensive, and extensively used in routine clini-
cal practice (24). The major part of CRP is synthesized by 
hepatocytes driven by interleukin-6, and genes associated 
with chronic inflammation are up-regulated in AAD (25). 
A significant increase in CRP and pro-inflammatory cytok-
ines was found in aortic dissection patients, suggesting 
its important role in the immunological pathways in AAD 
(26,27). Moreover, vessel wall inflammation, demonstrated 
with positron emission tomography in patients with AAD 
was associated with a higher risk of disease progression 
and adverse aortic events (1,2).
Therefore, similarly to acute coronary syndromes, inflam-
mation seems to play an important role in both the patho-
genesis and prognosis of AAD (4,5,28). It is plausible that 
the damaged aorta, due to the inflammatory process 
within the wall, may enlarge more easily and may be more 
prone to re-dissection and rupture.
In line with the results on the prognostic role of admission 
CRP, a recent study showed the prognostic role of peak CRP 
values for adverse long-term events in type B AAD (11). In 
addition, the CRP pattern obtained during hospitalization 
provided information regarding cardiovascular outcomes, 
and the behavior of CRP during hospital stay (ie, re-eleva-
tion, delayed recovery, and sustained elevation of CRP lev-
els) corresponded to intramural events (12-14). These data 
suggest that persistent inflammation corresponds to unfa-
vorable outcomes in AAD. Our systematic review showed 
that single admission CRP measurement proved to have 
a prognostic value in a cohort of patients with AAD. This 
suggests the need for a closer follow-up of these patients 
as they represent a vulnerable subgroup at a very high risk 
for adverse events.
Several other plasma inflammation markers were associ-
ated with unfavorable events in AAD. Liu et al (29) showed 
that low fibrinogen level on admission, due to the asso-
ciated consumption coagulopathy, was an independent 
predictor of in-hospital mortality in patients with type A 
AAD. Admission white blood cell count was a predictor 
of unfavorable short-term outcome in both type A and 
type B AAD, but its long-term prognostic value was lim-
ited (30,31).
Recently, Masaki et al (32) have shown that statin treatment 
due to its pleiotropic anti-inflammatory effects significantly 
inhibits the dilatation of the affected aortic segment in pa-
tients with uncomplicated type B aortic dissection, suggest-
ing that this therapeutic strategy may improve long-term 
outcomes. This is of importance, as patients with vascular 
diseases are far less likely to receive statin therapy com-
pared with patients having coronary artery disease (33).
A limitation of this study is that a pooled unified estimate 
of the strength of association between CRP and mortal-
ity could not be performed because of the relatively small 
number of primary studies included in this systematic re-
view, and the fact that included studies used different CRP 
cut-offs to classify patients.
In conclusion, our systematic review for the first time clear-
ly showed the prognostic value of admission CRP for both 
in-hospital and medium-term mortality in patients with 
AAD. Further prospective multicenter studies need to eval-
uate the prognostic role of CRP in the whole spectrum of 
acute aortic syndromes.
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